cannabidiolic acid has been researched along with cannabigerol in 5 studies
| Studies (cannabidiolic acid) | Trials (cannabidiolic acid) | Recent Studies (post-2010) (cannabidiolic acid) | Studies (cannabigerol) | Trials (cannabigerol) | Recent Studies (post-2010) (cannabigerol) |
|---|---|---|---|---|---|
| 76 | 1 | 68 | 103 | 3 | 89 |
| Protein | Taxonomy | cannabidiolic acid (IC50) | cannabigerol (IC50) |
|---|---|---|---|
| Inhibin alpha chain | Homo sapiens (human) | 5.2 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 3.31 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 3.46 | |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | 0.16 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 2.6 | |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 0.16 | |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | 1.3 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.5 | |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appendino, G; Giana, A; Gibbons, S; Grassi, G; Pagani, A; Rahman, MM; Smith, E; Stavri, M | 1 |
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Cunningham, CW | 1 |
| Anderson, LL; Arnold, JC; Bowen, MT; Cairns, EA; Fletcher, C; Heblinski, M; Krycer, JR; Martin, LJ; McGregor, IS | 1 |
| Cicero, N; Circosta, C; D'Angelo, V; Galati, EM; Giofrè, SV; Grassi, G; Monforte, MT; Smeriglio, A | 1 |
2 review(s) available for cannabidiolic acid and cannabigerol
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
Plant-Based Modulators of Endocannabinoid Signaling.
Topics: Cannabis; Endocannabinoids; Humans; Signal Transduction | 2019 |
3 other study(ies) available for cannabidiolic acid and cannabigerol
| Article | Year |
|---|---|
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
Topics: Acetylation; Anti-Bacterial Agents; Cannabinoids; Cannabis; Magnetic Resonance Spectroscopy; Methicillin Resistance; Methylation; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Structure-Activity Relationship | 2008 |
Cannabichromene and Δ
Topics: Cannabinoids; Cannabis; Databases, Chemical; Dronabinol; Enzyme Inhibitors; Lactate Dehydrogenase 5; Molecular Docking Simulation; Molecular Structure | 2021 |
Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
Topics: Aldehyde Reductase; Animals; Cannabidiol; Cannabinoids; Cannabis; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Plant Extracts; Recombinant Proteins; Swine | 2018 |